Chapter 45 Rational Antimicrobial Therapy

Antimicrobial Stewardship

  1. Dellit TH, Owens RC, McGowand JE, et al. 2007. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 44:159.
  2. Pile JC. 2011. Antimicrobial stewardship: optimizing antibiotic use in an era of increasing resistance and rising costs. J Hosp Med 6:S1. PUBMED Abstract
  3. Morley PS, Apley MD, Besser TE, et al. 2005. Antimicrobial drug use in veterinary medicine. J Vet Intern Med 19:617. PUBMED Abstract
  4. Cray C, Zaias J, Altman NH. 2009. Acute phase response in animals: a review. Comp Med 59:517. PUBMED Abstract
  5. Lorenzo-Figueras M, Pusterla N, Byrne BA, et al. 2006. In vitro evaluation of three bacterial culture systems for the recovery of Escherichia coli from equine blood. Am J Vet Res 67:2025. PUBMED Abstract
  6. CLSI. 2013. Performance standards for antimicrobial disk and dilution susceptibility test for bacteria isolated from animals; Approved Standard, ed 4, CLSI document VET01-A4. Clinical Laboratory Standards Institute, Wayne, PA.
  7. Turnidge J, Paterson DL. 2007. Setting and revising antibacterial susceptibility breakpoints. Clin Microbiol Rev 20:391. PUBMED Abstract
  8. Boothe DM. 2006. Principles of antimicrobial therapy. Vet Clin Small Anim Pract 36:1003. PUBMED Abstract
  9. McKinnon PS, Davis SL. 2004. Pharmacokinetic and pharmacodynamics issues in the treatment of bacterial infectious diseases. Eur J Clin Microb Infect Dis 23:271. PUBMED Abstract
  10. Schentag JJ, Meagher AK, Forrest A. 2003. Fluoroquinolone AUIC break points and the link to bacterial killing rates. Part 1: in vitro and animal models. Ann Pharmacother 37:1287. PUBMED Abstract
  11. Schentag JJ, Meagher AK, Forrest A. 2003. Fluoroquinolone AUIC break points and the link to bacterial killing rates. Part 2: human trials. Ann Pharmacother 37:1478. PUBMED Abstract
  12. Martinez M, Toutain PL, Walker RD. 2006. The pharmacokinetic-pharmacodynamic (PK/PD) relationship of antimicrobial agents, pp 81-106. In Giguere S, Prescott JF, Baggot JD, et al (eds), Antimicrobial therapy in veterinary medicine, ed 4. Blackwell Publishing, Ames, IA.
  13. Moellering RC, Eliopoulos GM. 2006. Principles of anti-infective therapy, pp 242-253. In Mandell GL, Bennett JE, Dolin R (eds), Mandell, Douglas, and Bennett's principles and practice of infectious diseases, ed 6. Elsevier, Philadelphia, PA.
  14. Lepper MH, Dowling HF. 1951. Treatment of pneumococcic meningitis with penicillin compared with penicillin plus aureomycin; studies including observations on an apparent antagonism between penicillin and aureomycin. AMA Arch Int Med 88:489. PUBMED Abstract
  15. Sande MA, Overton JW. 1973. In vivo antagonism between gentamicin and chloramphenicol in neutropenic mice. J Infect Dis 128:247. PUBMED Abstract
  16. Ensink JM, Klein WR, Mevius DJ, et al. 1992. Bioavailability of oral penicillins in the horse: a comparison of pivampicillin and amoxicillin. J Vet Pharmacol Ther 15:221. PUBMED Abstract
  17. Baggot JD, Short CR. 1984. Drug disposition in the neonatal animal, with particular reference to the foal. Equine Vet J 16:364. PUBMED Abstract
  18. Yabe K, Satoh H, Ishii Y, et al. 2004. Early pathophysiologic feature of arthropathy in juvenile dogs induced by ofloxacin, a quinolone antimicrobial agent. Vet Pathol 41:673. PUBMED Abstract
  19. Pfister K, Mazur D, Vormann J, et al. 2007. Diminished ciprofloxacin-induced chondrotoxicity by supplementation with magnesium and vitamin E in immature rats. Antimicrob Agents Chemother 51:1022. PUBMED Abstract
  20. Khaliq Y, Zhanel GG. 2003. Fluoroquinolone-associated tendinopathy: a critical review of the literature. Clin Infect Dis 36:1404. PUBMED Abstract
  21. Egerbacher M, Edinger J, Tschulenk W. 2001. Effects of enrofloxacin and ciprofloxacin hydrochloride on canine and equine chondrocytes in culture. Am J Vet Res 62:704. PUBMED Abstract
  22. Sansone JM, Wilsman NJ, Leiferman EM, et al. 2009. The effect of fluoroquinolone antibiotics on growing cartilage in the lamb model. J Pediatr Orthop 29:189. PUBMED Abstract
  23. Fenger CK, Granstrom DE, Langemeier JL, et al. 1997. Epizootic of equine protozoal myeloencephalitis on a farm. J Am Vet Med Assoc 210:923. PUBMED Abstract
  24. Bedford SJ, McDonnell SM. 1999. Measurements of reproductive function in stallions treated with trimethoprim-sulfamethoxazole and pyrimethamine. J Am Vet Med Assoc 215:1317. PUBMED Abstract
  25. Classen DC, Evans RS, Pestotnik SL, et al. 1992. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med 326:281. PUBMED Abstract
  26. Moore RM, Schneider RK, Kowalski J, et al. 1992. Antimicrobial susceptibility of bacterial isolates from 233 horses with musculoskeletal infection during 1979-1989. Equine Vet J 24:450. PUBMED Abstract
  27. Schneider RK, Bramlage LR, Moore RM, et al. 1992. A retrospective study of 192 horses affected with septic arthritis/tenosynovitis. Equine Vet J 24:436. PUBMED Abstract
  28. Barie PS, Eachempati SR. 2005. Surgical site infections. Surg Clin North Am 85:1115. PUBMED Abstract
  29. Bratzler DW, Houck PM. 2004. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 38:1706. PUBMED Abstract
  30. Southwood LL. 2006. Principles of antimicrobial therapy: what should we be using? Vet Clin North Am Equine Pract 22:279. PUBMED Abstract
  31. Johnson JC, Bryson WL, Barringer S, et al. 2008. Evaluation of on-arrival versus prompted metaphylaxis regimes using ceftiofur crystalline free acid for feedlot heifers at risk of developing bovine respiratory disease. Vet Ther 9:53. PUBMED Abstract
  32. Taylor JD, Fulton RW, Lehenbauer TW, et al. 2010. The epidemiology of bovine respiratory disease: what is the evidence for preventive measures? Can Vet J 51:1351. PUBMED Abstract
  33. Dunowska M, Morley PS, Traub-Dargatz JL. 2006. Impact of hospitalization and antimicrobial drug administration on antimicrobial susceptibility patterns of commensal Escherichia coli isolated from the feces of animals. J Am Vet Med Assoc 228:1909. PUBMED Abstract
  34. Maddox TW, Williams NJ, Clegg PD, et al. 2011. Longitudinal study of antimicrobial-resistant commensal Escherichia coli in the faeces of horses in an equine hospital. Prev Vet Med 100:134. PUBMED Abstract
  35. Ahmed MO, Williams NJ, Clegg PD, et al. 2012. Analysis of risk factors associated with antibiotic-resistant Escherichia coli. Microb Drug Resist 18:161. PUBMED Abstract
  36. Hall-Stoodley L, Stoodley P, Kathju S, et al. 2012. Toward diagnostic guidelines for biofilm-associated infections. FEMS Immunol Med Microbiol 65:127. PUBMED Abstract
  37. Muntener C, Bruckner L, Kupper J, et al. 2012. Vigilance for veterinary medicinal products: reports of adverse reactions in the year 2011. Schweiz Arch Tierheilkd 154:513. PUBMED Abstract
  38. Davis LE. 1985. Pharmacology, pp 35-77. In Veterinary values, ed 2. Ag Resources, New York.
  39. Paul JW. 1987. Drug interactions and incompatibilities. Vet Clin North Am Equine Pract 3:145. PUBMED Abstract

Medication Use in Food-Producing Animals

  1. U.S. Food and Drug Administration: Animal & Veterinary. 2009. Appendix III, Species and Classes of Major Food Animals. In CVM's Guidance for Industry (GFI) #191: Changes to Approved NADAs–New NADAs vs. Category II Supplemental NADAs. [WWW page]., accessed Feb 15, 2013. PUBMED Abstract
  2. U.S. Government Printing Office. 2013. Electronic Code of Federal Regulations, Title 9, Part 51.1. [WWW page]., accessed Feb 15, 2013.
  3. U.S. Food and Drug Administration (FDA). 2012. Code of Federal Regulations, Title 21, Part 530. Extra label drug use in animals. [WWW page]., accessed Feb 15, 2013.
  4. Riviere JE, Sundlof SF. 2009. Chemical residues in tissues of food animals. In Riviere JE, Papich MG (eds), Veterinary pharmacology & therapeutics, ed 9. Blackwell Publishing, Oxford.
  5. American Veterinary Medical Association. 2013. Animal Medicinal Drug Use Clarification Act (AMDUCA) Extralabel drug use algorithm. [WWW page]., accessed Feb 13, 2013.
  6. U.S. Food and Drug Administration (FDA). 2001. Extralabel use of medicated feeds for minor species (CPG615.115)., accessed Feb 15, 2013.
  7. Davis JL, Smith GW, Baynes RE, et al. 2009. Update on drugs prohibited from extralabel use in food animals. J Am Vet Med Assoc 235:528. PUBMED Abstract
  8. Food Animal Residue Avoidance and Depletion. 2013. Restricted and Prohibited Drugs in Food Animals. [WWW page]., accessed Feb 15, 2013.
  9. American Veterinary Medical Association. 2013. Animal Medicinal Drug Use Act (AMDUCA). [WWW page]., accessed Feb 15, 2013.
  10. U.S. Food and Drug Administration. 2012. CFR Title 21 Sec. 530.41, Drugs prohibited for extralabel use in animals. [WWW page]., accessed Feb 15, 2013.
  11. Martínez-Navarro JF. 1990. Food poisoning related to consumption of illicit β-agonist in liver. Lancet 336:1311. PUBMED Abstract
  12. Brambilla G, Loizzo A, Fontana L, et al. 1997. Food poisoning following consumption of clenbuterol-treated veal in Italy. J Am Med Assoc 278:635. PUBMED Abstract
  13. Payne MA. 2001. Anti-inflammatory therapy in dairy cattle: therapeutic and regulatory considerations. California Vet 55:10.
  14. U.S. Food and Drug Administration (FDA). 2010. Compounding of drugs for use in animals (CPG7125.40). [WWW page]., accessed Feb 15, 2013.
  15. Haskell SRR, Payne MA, Webb A, et al. 2005. Antidotes in food animal practice. J Am Vet Med Assoc 226:884. PUBMED Abstract
  16. Baynes RE, Martin-Jimenez T, Craigmill AL, et al. 1999. Estimating provisional acceptable residues for extralabel drug use in livestock. Regul Toxicol Pharmacol 29:287. PUBMED Abstract
  17. Martin-Jimenez T, Bayens RE, Craigmill A, et al. 2002. Extrapolated withdrawal-interval estimator (EWE) algorithm: a quantitative approach to establishing extralabel withdrawal times. Regul Toxicol Pharmacol 36:131.
  18. Riviere JE, Webb AI, Craigmill AL. 1998. Primer on estimating withdrawal times after extralabel drug use. J Am Vet Med Assoc 213:966. PUBMED Abstract
  19. U.S. Government Printing Office. 2012. Federal Register notice announcing changes to FSIS testing methodology (Docket No. FSIS-2012-0012). [WWW page]., accessed Feb 15, 2013.